chr16-10770278-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001079512.4(TVP23A):āc.636G>Cā(p.Gln212His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,551,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001079512.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152252Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000975 AC: 15AN: 153850Hom.: 0 AF XY: 0.0000613 AC XY: 5AN XY: 81510
GnomAD4 exome AF: 0.0000250 AC: 35AN: 1398662Hom.: 0 Cov.: 31 AF XY: 0.0000232 AC XY: 16AN XY: 689928
GnomAD4 genome AF: 0.000112 AC: 17AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.000174 AC XY: 13AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.636G>C (p.Q212H) alteration is located in exon 7 (coding exon 7) of the TVP23A gene. This alteration results from a G to C substitution at nucleotide position 636, causing the glutamine (Q) at amino acid position 212 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at